A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2011
10/12/2011	CN102210692A Application of pseudojujubogenin in preparation of antidepressant medicaments
10/12/2011	CN102210678A Application of CPURS86017 in treating anoxia concurrent testis and cerebral lesion
10/12/2011	CN102210671A Application of inula flavonoid in preparing medicament for preventing and treating Alzheimer's disease
10/12/2011	CN102210666A Medical use of salvianolic acid A
10/12/2011	CN102210664A Implant for treating glioblastoma and preparation method thereof
10/12/2011	CN102210663A Diarylalkanes as potent inhibitors of binuclear enzymes
10/12/2011	CN102210658A Microcapsule soft capsule preparation with high alpha-linolenic acid content
10/12/2011	CN102210653A Burdock aglycone microemulsion
10/12/2011	CN102210535A Neck soothing healing device
10/12/2011	CN101879281B Formula of honey refined gum for treating chloasma and preparation method thereof
10/12/2011	CN101590086B Fructus akebiae extract, preparation and application thereof
10/12/2011	CN101415680B Benzoisoindole derivatives for the treatment of pain
10/12/2011	CN101396358B Oxiracetam injection
10/12/2011	CN101301336B Decoction medicament for treating localized neurodermatitis
10/12/2011	CN101258134B 2-(4-oxo-4H-quinazolin-3-yl) acetamides and their use as vasopressin V3 antagonists
10/11/2011	US8034958 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
10/11/2011	US8034955 triterpenoids such as 2-cyano-3,12-dioxoolean-1,9-dien-28oic acid, used for inhibiting gamma -inteferon-induced nitric oxide production in macrophages; preventing cancer, Alzheimer's disease, Parkinson's disease, inflammatory bowel diseases, and multiple sclerosis
10/11/2011	US8034954 Calcium channel antagonists
10/11/2011	US8034933 graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides
10/11/2011	US8034820 Pharmaceutical composition
10/11/2011	US8034818 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates
10/11/2011	US8034814 Phthalazine derivatives with angiogenesis inhibiting activity
10/11/2011	US8034804 (Pyrido/thieno)-[f]-oxazepine-5-one derivatives
10/11/2011	US8034799 Preventing and/or treating cardiovascular disease and/or associated heart failure
10/11/2011	US8034798 Use of 3-methoxy-pregnenolone in the production of a medicament for treating neurodegenerative diseases
10/11/2011	US8034379 Hydrophilic gel foaming matrix; cellulose ethers
10/11/2011	US8034348 Prevention and treatment of amyloidogenic disease
10/11/2011	US8034346 Methods for treating pain by administering a nerve growth factor antagonist and an NSAID and compositions containing the same
10/11/2011	US8034339 administering an antibody that specifically binds to the amyloid deposit or a component thereof; can be a human, humanized, chimeric or nonhuman antibody and can be monoclonal or polyclonal; also a novel monoclonal antibody which specifically binds to an epitope within residues 13-28 of A beta
10/11/2011	CA2682494C Hexahydro-1h-4,7-methanoisoindole-1,3-dione compounds for treating psychiatric disorders
10/11/2011	CA2655395C Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same
10/11/2011	CA2555216C Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
10/11/2011	CA2524640C 2, 3, 4, 5-tetrahydrobenzo[f][1,4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease
10/11/2011	CA2520852C 7-([1,4]dioxan-2-yl)-benzothiazole derivative as adenosine receptor ligands
10/11/2011	CA2494235C C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
10/11/2011	CA2494100C Pyrazole compositions useful as inhibitors of gsk-3
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases
10/11/2011	CA2481561C Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity
10/11/2011	CA2472479C Deazapurines and uses thereof
10/11/2011	CA2471436C Non-sedating barbituric acid derivatives
10/11/2011	CA2464578C Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient
10/11/2011	CA2464322C Methods of treatment using a gastric retained gabapentin dosage
10/11/2011	CA2457054C Activator of peroxisome proliferator-activated receptor .delta.
10/11/2011	CA2453978C Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors
10/11/2011	CA2420537C A composition for treatment of parkinson's disease
10/11/2011	CA2400482C Bupropion metabolites and methods of their synthesis and use
10/11/2011	CA2394862C Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder
10/06/2011	WO2011123866A1 Abuse-deterrent transdermal formulations of opiate agonists and agonist-antagonists
10/06/2011	WO2011123863A1 Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugs
10/06/2011	WO2011123842A2 Methods for treating parkinson's disease and other disorders of dopaminergic neurons of the brain
10/06/2011	WO2011123719A2 Use of faah inhibitors for treating abdominal, visceral and pelvic pain
10/06/2011	WO2011123674A1 Compounds for treating neurodegenerative diseases
10/06/2011	WO2011123654A1 Compositions and methods of synthesis of pyridinoylpiperidine 5-ht1f agonists
10/06/2011	WO2011123482A1 Purine compounds used as cb2 agonists
10/06/2011	WO2011123372A1 Purine compounds
10/06/2011	WO2011123042A1 Vaccination procedure and products for use therein
10/06/2011	WO2011122879A2 Composition comprising coumestrol or a bean extract containing coumestrol
10/06/2011	WO2011122872A2 Composition comprising coumestrol or a bean extract containing coumestrol
10/06/2011	WO2011122701A1 Method for treating schizophrenia and related diseases
10/06/2011	WO2011122619A1 Phenylalanine derivative salt crystal
10/06/2011	WO2011122458A1 Aromatic ring compound containing nitrogen
10/06/2011	WO2011122041A1 Expression modulator for clock gene period
10/06/2011	WO2011122040A1 Expression modulator for clock gene bmal
10/06/2011	WO2011121645A1 Amyloid fibril formation inhibitor
10/06/2011	WO2011121607A2 Rasagiline and its pharmaceutically acceptable salts
10/06/2011	WO2011121418A1 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists
10/06/2011	WO2011121351A1 Use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy
10/06/2011	WO2011121309A1 Phenyl sulfonyl derivatives and their use as histamine h3 antagonists
10/06/2011	WO2011121151A1 Functional food supplement intended, in particular, for nutrition and for prevention and improvement in cases of neurological alterations, neurodegenerative alterations or cognitive disorders
10/06/2011	WO2011121150A1 Enteral or oral food product intended, in particular, for nutrition and for the prevention and improvement of neurological alterations, neurodegenerative alterations or cognitive disorders
10/06/2011	WO2011121137A1 Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders
10/06/2011	WO2011120969A1 Concentration-enhancing drink
10/06/2011	WO2011120924A1 Composition comprising the amyloid beta 1-6 peptide coupled to a virus-like particle and an adjuvant
10/06/2011	WO2011120281A1 Use of l-oxiracetam in manufacture of medicaments for preventing or treating cognitive dysfunction
10/06/2011	WO2011120084A1 Transdermal delivery patch
10/06/2011	WO2011120082A1 A method of modulating protein 14-3-3 functionality by facilitating or inhibiting phosphorylation
10/06/2011	WO2011120071A1 Oxytocin peptide analogues
10/06/2011	WO2011120070A1 Transdermal delivery patch
10/06/2011	WO2011085216A3 Use of faah inhibitors for treating parkinson's disease and restless legs syndrome
10/06/2011	WO2011063989A3 Treatment of nerve injuries
10/06/2011	WO2011063164A3 Sustained release cannabinoid medicaments
10/06/2011	WO2011044537A9 Methods for treating alzheimer's disease
10/06/2011	WO2011041451A3 Smoking cessation with body weight maintenance and nutritional supplement
10/06/2011	WO2011019956A3 Pharmaceutical compositions with tetrabenazine
10/06/2011	US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins
10/06/2011	US20110245798 Method of Treating Parkinson's Disease in Humans by Convection-Enhanced Infusion of Glial Cell-Line Derived Neurotrophic Factor to the Putamen
10/06/2011	US20110245346 Novel polymorphs and salts
10/06/2011	US20110245323 RIG-Like Helicase Innate Immunity Inhibits VEGF-Induced Tissue Responses
10/06/2011	US20110245322 Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of cf-associated mutant cystic fibrosis transmembrane conductance regulator
10/06/2011	US20110245313 Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function
10/06/2011	US20110245312 Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function
10/06/2011	US20110245307 Methods for Alzheimer's Disease Treatment and Cognitive Enhancement
10/06/2011	US20110245297 Use Quaternary Pyridinium Salts as Vasoprotective Agents
10/06/2011	US20110245291 Tricyclic delta-opioid modulators
10/06/2011	US20110245288 Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugs
10/06/2011	US20110245287 Hybrid Opioid Compounds and Compositions
10/06/2011	US20110245272 Pyrido[4,3-b]indoles and methods of use
10/06/2011	US20110245271 Triazole-substituted arylamides as p2x3 and p2x2/3 antagonists
10/06/2011	US20110245267 Piperidine and piperazine derivatives and methods of use thereof
10/06/2011	US20110245266 Pyridin-2-one compounds and their use as modulators of the dopamine d3 receptor

1 ... 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 ... 1833